Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome

Obstetrics and Gynecology

Volumn 92, Issue 3, 1998, Pages 457-460

  Krauss, Thomas ^a   Augustin, Hellmut G ^a   Osmers, Rüdiger ^a   Meden, Harald ^a   Unterhalt, Michael ^b   Kuhn, Walther ^a  

^a Dept Gynecol Obstet Univ G ^*  (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GENE MUTATION; HELLP SYNDROME; HEMOLYSIS; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK FACTOR; THIRD TRIMESTER PREGNANCY; THROMBOCYTE;

ADULT; FACTOR V; FEMALE; HELLP SYNDROME; HETEROZYGOTE; HUMANS; MIDDLE AGED; PREGNANCY; PROTEIN C; RISK FACTORS;

EID: 0031652735     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00208-7     Document Type: Article

References (19)

1. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 169:1993;1000-1006.
2. Meden H., Armstrong V.W., Arendt H., Cunze T., Kuhn W. HELLP syndrome Prognosis and parameters of hemolysis with special regard to haptoglobin . Singapore J Obstet Gynaecol. 27:1996;42-48.
3. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count A severe consequence of hypertension in pregnancy . Am J Obstet Gynecol. 142:1982;159-167.
4. Rath W., Loos W., Kuhn W., Graeff H. The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 36:1990;43-51.
5. Sibai B.M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) Much ado about nothing? Am J Obstet Gynecol. 162:1990;311-316.
6. Wilke G., Rath W., Schütz E., Armstrong V.W., Kuhn W. Haptoglobin as a sensitive marker of hemolysis in HELLP syndrome. Int J Gynaecol Obstet. 39:1992;29-34.
7. de Boer K., Büller H.R., Ten Cate J.W., Treffers P.E. Coagulation studies in the syndrome of hemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol. 98:1991;42-47.
8. Dekker G.A., de Vries J.I., Doelitzsch P.M., Huijgens P.C., von Blomberg B.M., Jakobs C., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 173:1995;1042-1048.
9. Faught W., Garner P., Jones G., Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol. 172:1995;147-150.
10. Dahlbäck B., Carlsson M., Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C Prediction of a cofactor to activated protein C . Proc Natl Acad Sci U S A. 90:1993;1004-1008.
11. Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med. 237:1995;221-227.
12. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
13. Rees D.C., Cox M., Clegg J.B. World distribution of Factor V Leiden. Lancet. 346:1995;1133-1134.
14. Pabinger I., Kyrle P.A., Heistinger M., Eichinger S., Wittmann E., Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency A prospective cohort study . Thromb Haemost. 71:1994;441-445.
15. Miletich J., Sherman L., Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 317:1987;991-996.
16. Hellgren M., Svensson P.J., Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 173:1995;210-213.
17. Dizon-Townson D.S., Nelson L.M., Easton K., Ward K. The Factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol. 175:1996;902-905.
18. Brenner B., Lanir N., Thaler I. HELLP syndrome associated with Factor V R506Q mutation. Br J Haematol. 92:1996;999-1001.
19. Bertina R.M. Laboratory findings of resistance to activated protein C (APC-resistance). Thromb Haemost. 78:1997;478-482.